JPRN-UMIN000020335招募中未知
Improvement of efficacy in Crohn's disease by early use of infliximab - Early use of infliximab in Crohn's disease
IBD Relapse Prevention Team0 个研究点目标入组 100 人开始时间: 2015年12月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
- Chiba M et al. Induction with infliximab and a plant-based diet as first-line (IPF) therapy for Crohn disease: A Single-group trial. Perm J 2017;21:17-009 2) Chiba M et al. How to avoid primary non-responders to infliximab in Crohn's disease. Inflamm Bowel Dis 2017;23:E55-E56 3) Chiba M et al. Relapse-free course in nearly half of Crohn's disease patients with infliximab and plant-based diet as first-line (IPF) therapy: Single-group trial. Perm J 2022;26:21.073
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 10years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patient who was initially treated by steroid or immunosuppressants
研究者
相似试验
已完成
4 期
Infliximab for the Prevention of Recurrent Crohn's Disease After SurgeryCrohn's DiseaseNCT00688636University of Pittsburgh24
Unknown
不适用
Diet as Essential Therapy (DIET) for Inflammatory Bowel DiseaseCrohn DiseaseNCT03012542University of Washington32
已完成
不适用
IDeaL Pilot Study - Infliximab Dose to Level: Pilot StudyCrohn's DiseaseInflammatory Bowel DiseaseNCT02847884University of Alberta28
Unknown
4 期
Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab TherapyCrohn's DiseaseNCT00851565Copenhagen University Hospital at Herlev120
已完成
3 期
A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's DiseaseCrohn DiseaseNCT00207766Centocor, Inc.306